Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PETRO Extension Trial (PETRO-Ex)
NCT00157248Phase 2Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2003
- Primary completion
- Jan 2009
- Countries
- 4
01
Overview
A Phase 2 trial of dabigatran in Atrial fibrillation (AFib), sponsored by Boehringer Ingelheim. Started Dec 2003; status: terminated.
02
Drugs
dabigatran
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00157248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157248.